New white paper on the cost of SLD

We are excited to share our latest white paper, shedding light on a hidden healthcare crisis from a health economic perspective. With one billion people at risk, paired with inefficient patient pathways, steatotic liver disease has a heavy financial burden on our healthcare systems and society as a whole. Our white paper delves deep into this economic burden, advocating for a paradigm shift towards preventive care and early detection.

Key takeaways from our white paper include:

• Understanding the cost of SLD to society and healthcare systems.

• The need for a shift towards preventive care.

• The importance of accurate risk stratification in primary care.

• Addressing the challenges of late-stage diagnosis.

• New data-driven technologies for more cost-effective testing.

• A cost comparison study highlighting potential savings.

By introducing a proactive approach to ensure timely management of SLD, we can improve patient outcomes, reduce the burden on our healthcare systems, and ultimately curb the rise of this silent pandemic.

‍

Find it here: https://www.evido.health/publications-and-news